Table 3.
Follow-up outcome.
| Characteristics | Total | Stent Thrombosis |
p-value | |
|---|---|---|---|---|
| No | Yes | |||
| N | 569 | 536 | 33 | – |
| Follow-up duration (months) | ||||
| Range | 22–16 | 22–16 | 21–16 | 0.259 |
| Mean ± SD | 18.08 ± 1.76 | 18.1 ± 1.76 | 17.76 ± 1.71 | |
| Median [IQR] | 18 [20–16] | 18 [20–16.5] | 18 [19–16] | |
| Follow-up outcomes | ||||
| Expired | 10.9% (62) | 6.9% (37) | 75.8% (25) | <0.001 |
| Re-admission within 30 days | 2.3% (13) | 1.3% (7) | 18.2% (6) | <0.001 |
| Expired within 30 days | 4.4% (25) | 0% (0) | 75.8% (25) | <0.001 |
| Re MI | 3% (17) | 0.4% (2) | 45.5% (15) | <0.001 |
| Re Intervention | 2.5% (14) | 0.7% (4) | 30.3% (10) | <0.001 |
| Stent Thrombosis (ST) | 5.8% (33) | – | 100% (33) | – |
| Definite | 0.5% (3) | – | 9.1% (3) | – |
| Probable | 5.3% (30) | – | 90.9% (30) | |
| Acute Stent Thrombosis | 0.5% (3) | – | 9.1% (3) | – |
| Sub-acute Stent Thrombosis | 5.3% (30) | – | 90.9% (30) | – |
SD = standard deviation.
IQR = interquartile range.